T-Lymphocytes

"T-Lymphocytes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen.

Descriptor ID	D013601
MeSH Number(s)	A11.118.637.555.567.569 A15.145.229.637.555.567.569 A15.382.490.555.567.569
Concept/Terms	T-Lymphocytes T-Lymphocytes T Lymphocytes T-Lymphocyte T-Cells T Cells T-Cell Thymus-Dependent Lymphocytes Lymphocyte, Thymus-Dependent Lymphocytes, Thymus-Dependent Thymus Dependent Lymphocytes Thymus-Dependent Lymphocyte

Below are MeSH descriptors whose meaning is more general than "T-Lymphocytes".

Anatomy [A]
Cells [A11]
Blood Cells [A11.118]
Leukocytes [A11.118.637]
Leukocytes, Mononuclear [A11.118.637.555]
Lymphocytes [A11.118.637.555.567]
T-Lymphocytes [A11.118.637.555.567.569]
Hemic and Immune Systems [A15]
Blood [A15.145]
Blood Cells [A15.145.229]
Leukocytes [A15.145.229.637]
Leukocytes, Mononuclear [A15.145.229.637.555]
Lymphocytes [A15.145.229.637.555.567]
T-Lymphocytes [A15.145.229.637.555.567.569]
Immune System [A15.382]
Leukocytes [A15.382.490]
Leukocytes, Mononuclear [A15.382.490.555]
Lymphocytes [A15.382.490.555.567]
T-Lymphocytes [A15.382.490.555.567.569]

Below are MeSH descriptors whose meaning is related to "T-Lymphocytes".

Below are MeSH descriptors whose meaning is more specific than "T-Lymphocytes".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "T-Lymphocytes" by people in this website by year, and whether "T-Lymphocytes" was a major or minor topic of these publications.

Bar chart showing 258 publications over 31 distinct years, with a maximum of 22 publications in 2007 and 2010

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	0	1	1
1994	3	0	3
1995	4	0	4
1996	0	1	1
1997	1	0	1
1998	0	1	1
1999	3	1	4
2000	2	1	3
2001	2	0	2
2002	2	5	7
2003	10	8	18
2004	8	8	16
2005	9	4	13
2006	7	7	14
2007	12	10	22
2008	6	7	13
2009	4	11	15
2010	13	9	22
2011	4	4	8
2012	7	4	11
2013	2	1	3
2014	5	3	8
2015	4	5	9
2016	4	3	7
2017	4	2	6
2018	6	2	8
2019	3	0	3
2020	7	2	9
2021	3	1	4
2022	1	13	14
2023	1	7	8

Below are the most recent publications written about "T-Lymphocytes" by people in Profiles.

Shah I, Chiang S, Yang L, Akeno N, Kelly A, White J, Caywood E, Hwang S, Le T. ?d CD8+ T cells and novel genetic variants in ZAP70 deficiency. Pediatr Allergy Immunol. 2023 10; 34(10):e14035.

View in: PubMed
Seyedin R, Snider JT, Rajagopalan K, Wade SW, Gergis U. Chimeric antigen receptor T-cell treatment patterns in relapsed or refractory large B-cell lymphoma. Future Oncol. 2023 Jul; 19(22):1535-1547.

View in: PubMed
Cowan AJ, Pont MJ, Sather BD, Turtle CJ, Till BG, Libby EN, Coffey DG, Tuazon SA, Wood B, Gooley T, Wu VQ, Voutsinas J, Song X, Shadman M, Gauthier J, Chapuis AG, Milano F, Maloney DG, Riddell SR, Green DJ. ?-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial. Lancet Oncol. 2023 Jul; 24(7):811-822.

View in: PubMed
Tarke A, Zhang Y, Methot N, Narowski TM, Phillips E, Mallal S, Frazier A, Filaci G, Weiskopf D, Dan JM, Premkumar L, Scheuermann RH, Sette A, Grifoni A. Targets and cross-reactivity of human T?cell recognition of common cold coronaviruses. Cell Rep Med. 2023 06 20; 4(6):101088.

View in: PubMed
Domeier PP, Rahman ZSM, Ziegler SF. B cell- and T cell-intrinsic regulation of germinal centers by thymic stromal lymphopoietin signaling. Sci Immunol. 2023 01 06; 8(79):eadd9413.

View in: PubMed
Contreras AV, Wiest DL. Development of ?d T Cells: Soldiers on the Front Lines of Immune Battles. Methods Mol Biol. 2023; 2580:71-88.

View in: PubMed
Sertori R, Zhang Y, Wiest DL. Zebrafish: A Tractable Model for Analysis of T Cell Development. Methods Mol Biol. 2023; 2580:355-377.

View in: PubMed
Gleason L, Nikbakht N. Prognostic Relevance of Dominant Blood T-Cell Clones in Early Mycosis Fungoides. JAMA Dermatol. 2023 Jan 01; 159(1):116.

View in: PubMed
Tilsed CM, Principe N, Kidman J, Chin WL, Orozco Morales ML, Zemek RM, Chee J, Islam R, Fear VS, Forbes C, Aston WJ, Jansen M, Chopra A, Lassmann T, Nowak AK, Fisher SA, Lake RA, Lesterhuis WJ. CD4+ T?cells drive an inflammatory, TNF-a/IFN-rich tumor microenvironment responsive to chemotherapy. Cell Rep. 2022 12 27; 41(13):111874.

View in: PubMed
Yi D, Gergis M, Hsu J, Yang Y, Bi X, Aljurf M, Gergis U. Next-Generation Chimeric Antigen Receptor T-cells. Hematol Oncol Stem Cell Ther. 2022 Dec 15; 15(3):117-121.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement